GB

Greg Blake

Zelira Therapeutics Limited | Executive Director
Mr Blake has led the strategic development and commercialisation of several products across various therapeutic categories. He has nearly 20 years of experience in healthcare, building a foundation of knowledge across marketing and the commercial value chain. His work with Rhythm Biosciences as General Manager led the company through the establishment of the pre-launch critical pathway and commercialisation planning for both domestic and international markets.

Company and Role

Company
Title
Tenure
Since
ZLD
ZLD
Zelira Therapeutics Limited
  • Executive Director
3yrs, 4mthFeb 2023

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ZLD
ZLD
Zelira Therapeutics Limited
30/06/25N/AN/A175,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ZLD
ZLD
Zelira Therapeutics Limited
24/11/23
Issued
175,000$0.473$82,836Director remuneration
ZLD
ZLD
Zelira Therapeutics Limited
11/09/23
Expiry
114,290$0.990$113,147Options expired